Concepedia

S. Thomas Forgue

ST

Statistics

Publications

22

Citations

1.4K

H-Index

18

Active since

1978

Affiliations

Eli Lilly (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (United States)

University of Wisconsin–Madison

Universidad de Navarra

S. Thomas Forgue is an author at Eli Lilly (United States) specializing in pharmacokinetics, pharmacology, and pharmacy.

Publications per year

1978–2007

22

Publications

22

Tadalafil pharmacokinetics in healthy subjects

S. Thomas Forgue, Beverley Patterson, Alun Bedding et al. · British Journal of Clinical Pharmacology · 2005 · 283 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +15

Pharmacokinetics of cefepime in subjects with renal insufficiency

Rashmi H. Barbhaiya, Catherine A. Knupp, S. Thomas Forgue et al. · Clinical Pharmacology & Therapeutics · 1990 · 130 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects

Rashmi H. Barbhaiya, S. Thomas Forgue, Carol Gleason et al. · Antimicrobial Agents and Chemotherapy · 1992 · 125 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Model-Based Drug Development: The Road to Quantitative Pharmacology

Liping Zhang, Vikram Sinha, S. Thomas Forgue et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2006 · 109 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure

Edward Abraham, Chris Naum, Venkata Bandi et al. · Critical Care Medicine · 2003 · 101 citations

Veterinary Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 22